Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

JAMP OSELTAMIVIR DIN 02497417

Status: Approved
Holder: JAMP PHARMA CORPORATION
Molecule: OSELTAMIVIR (OSELTAMIVIR PHOSPHATE)

Health Canada record

Active ingredient(s)OSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ05AH02 OSELTAMIVIR
Original market date
Current status date20-Mar-2020
SourceHealth Canada DPD

Establishment licence of the holder

Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing OSELTAMIVIR (OSELTAMIVIR PHOSPHATE)

DINProductCompanyFormStrengthStatus
02536919ACH-OSELTAMIVIR PHOSPHATEACCORD HEALTHCARE INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGApproved
02536900ACH-OSELTAMIVIR PHOSPHATEACCORD HEALTHCARE INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGApproved
02536897ACH-OSELTAMIVIR PHOSPHATEACCORD HEALTHCARE INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGApproved
02510251AG-OSELTAMIVIRANGITA PHARMA INC.CapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGApproved
02510286AG-OSELTAMIVIRANGITA PHARMA INC.CapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGApproved
02510278AG-OSELTAMIVIRANGITA PHARMA INC.CapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGApproved
02497425JAMP OSELTAMIVIRJAMP PHARMA CORPORATIONCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGMarketed
02497409JAMP OSELTAMIVIRJAMP PHARMA CORPORATIONCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGMarketed
02497441MINT-OSELTAMIVIRMINT PHARMACEUTICALS INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGMarketed
02497476MINT-OSELTAMIVIRMINT PHARMACEUTICALS INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGMarketed
02497468MINT-OSELTAMIVIRMINT PHARMACEUTICALS INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGApproved
02472643NAT-OSELTAMIVIRNATCO PHARMA (CANADA) INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGMarketed
02499894NAT-OSELTAMIVIRNATCO PHARMA (CANADA) INCPowder For SuspensionOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 6 MGMarketed
02472635NAT-OSELTAMIVIRNATCO PHARMA (CANADA) INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGMarketed
02457989NAT-OSELTAMIVIRNATCO PHARMA (CANADA) INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGMarketed
02509962OSELTAMIVIR POWDER FOR ORAL SUSPENSIONSTRIDES PHARMA CANADA INCPowder For SuspensionOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 6 MGApproved
02504006SANDOZ OSELTAMIVIRSANDOZ CANADA INCORPORATEDCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGMarketed
02504022SANDOZ OSELTAMIVIRSANDOZ CANADA INCORPORATEDCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGMarketed
02504014SANDOZ OSELTAMIVIRSANDOZ CANADA INCORPORATEDCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGMarketed
02241472TAMIFLUHOFFMANN-LA ROCHE LIMITEDCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGMarketed
02304856TAMIFLUHOFFMANN-LA ROCHE LIMITEDCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGMarketed
02304848TAMIFLUHOFFMANN-LA ROCHE LIMITEDCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGMarketed
02381842TAMIFLUHOFFMANN-LA ROCHE LIMITEDPowder For SuspensionOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 6 MGMarketed
02497379MAR-OSELTAMIVIRMARCAN PHARMACEUTICALS INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGCancelled Post Market
02497352MAR-OSELTAMIVIRMARCAN PHARMACEUTICALS INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGCancelled Post Market
02497360MAR-OSELTAMIVIRMARCAN PHARMACEUTICALS INCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGCancelled Post Market
02478439MYLAN-OSELTAMIVIRMYLAN PHARMACEUTICALS ULCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 75 MGCancelled Pre Market
02478412MYLAN-OSELTAMIVIRMYLAN PHARMACEUTICALS ULCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 30 MGCancelled Pre Market
02478420MYLAN-OSELTAMIVIRMYLAN PHARMACEUTICALS ULCCapsuleOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 45 MGCancelled Pre Market
02245549TAMIFLU ORAL SUSPENSIONHOFFMANN-LA ROCHE LIMITEDPowder For SuspensionOSELTAMIVIR (OSELTAMIVIR PHOSPHATE) 12 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
233732020-03-20Abbreviated New Drug Submission (ANDS)
Request a quote for JAMP OSELTAMIVIR

How to read a Canadian DIN record